| Financial Year |
March 31 2023 |
| Monetary Funds |
1,839,515,245.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,703,477.90 |
| Accounts Receivable |
560,074,328.68 |
| Advances to Suppliers |
109,883,284.60 |
| Other Receivables |
90,972,188.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
11,377,534.25 |
| Inventories |
150,914,007.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
367,444,139.42 |
| Total Current Assets |
3,121,506,672.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,329,725,960.57 |
| Investment Properties |
1,222,485.00 |
| Fixed Assetes |
4,080,482,407.90 |
| Under-construction Projects |
1,435,083,517.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
422,104,658.67 |
| R&D expenses |
654,716.98 |
| Goodwill |
10,565,751.96 |
| Long-Term Deferred and Prepaid Expenses |
69,488,747.63 |
| Deferred Income Tax Assets |
585,196,905.63 |
| Other Non-Current Assets |
364,404,257.23 |
| Sub-Total of Non-Current Assets |
13,134,715,204.97 |
| Total Assets |
16,256,221,877.52 |
| Short-Term Loans |
1,346,947,928.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
658,510,304.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,927,047.74 |
| Taxes Payable |
61,164,492.33 |
| Interest Payable |
-- |
| Dividend Payable |
96,794.93 |
| Other payables |
36,862,973.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
253,058,116.00 |
| Other Current Liabilities |
56,561,409.50 |
| Sub-Total of Current Liabilities |
2,501,858,901.04 |
| Long-term Loans |
6,042,002,427.76 |
| Bonds Payable |
1,600,000,000.00 |
| Long-Term Accounts Payable |
86,993,466.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,262,932.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,102,632,485.79 |
| Total Liabilities |
10,604,491,386.83 |
| Paid-In Capital(Or Share Stock) |
822,099,384.00 |
| Capital Surplus |
1,020,617,127.59 |
| Surplus Reserve |
535,128,066.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,607,621,357.51 |
| Minority Stockholder's Interest |
606,473,403.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,045,257,087.20 |
| Owner's Equity（Stockholder's Equity） |
5,651,730,490.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,256,221,877.52 |
